X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4196) 4196
Publication (462) 462
Book Review (75) 75
Book Chapter (10) 10
Magazine Article (6) 6
Dissertation (4) 4
Reference (3) 3
Web Resource (2) 2
Conference Proceeding (1) 1
Paper (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3518) 3518
imatinib mesylate (3046) 3046
index medicus (2374) 2374
benzamides (1816) 1816
oncology (1785) 1785
male (1715) 1715
female (1690) 1690
middle aged (1493) 1493
imatinib (1482) 1482
pyrimidines - therapeutic use (1433) 1433
antineoplastic agents - therapeutic use (1338) 1338
piperazines - therapeutic use (1301) 1301
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (1291) 1291
pyrimidines - adverse effects (1275) 1275
adult (1262) 1262
aged (1138) 1138
piperazines - adverse effects (1137) 1137
hematology (1123) 1123
antineoplastic agents - adverse effects (1074) 1074
chronic myelogenous leukemia (959) 959
treatment outcome (924) 924
chronic myeloid leukemia (866) 866
chronic myeloid-leukemia (856) 856
protein kinase inhibitors - therapeutic use (769) 769
cancer (761) 761
pyrimidines - administration & dosage (654) 654
care and treatment (606) 606
piperazines - administration & dosage (579) 579
leukemia (563) 563
therapy (545) 545
dasatinib (532) 532
protein kinase inhibitors - adverse effects (529) 529
protein-tyrosine kinases - antagonists & inhibitors (515) 515
tyrosine kinase inhibitor (507) 507
medicine & public health (482) 482
antineoplastic agents - administration & dosage (479) 479
pharmacology & pharmacy (458) 458
antineoplastic agents (443) 443
research (438) 438
aged, 80 and over (436) 436
drug therapy (436) 436
animals (430) 430
adolescent (428) 428
tyrosine (424) 424
mesylate (420) 420
gastrointestinal stromal tumors - drug therapy (416) 416
antimitotic agents (410) 410
tyrosine kinase inhibitors (396) 396
bcr-abl (383) 383
young adult (373) 373
chemotherapy (372) 372
prognosis (367) 367
hemic and lymphatic diseases (355) 355
nilotinib (349) 349
tumors (340) 340
mutation (335) 335
analysis (331) 331
gastrointestinal stromal tumors (328) 328
hematology, oncology and palliative medicine (324) 324
drug resistance, neoplasm (320) 320
pyrimidines - pharmacology (316) 316
cml (308) 308
leukemia, myelogenous, chronic, bcr-abl positive - genetics (303) 303
tyrosine kinase (302) 302
disease-free survival (298) 298
health aspects (285) 285
antineoplastic agents - pharmacology (282) 282
piperazines - pharmacology (281) 281
c-kit (278) 278
follow-up studies (278) 278
leukemia, myelogenous, chronic, bcr-abl positive - pathology (269) 269
retrospective studies (264) 264
follow-up (261) 261
protein kinase inhibitors - administration & dosage (260) 260
antineoplastic combined chemotherapy protocols - therapeutic use (254) 254
risk factors (251) 251
chronic-phase (242) 242
gist (241) 241
diagnosis (240) 240
fusion proteins, bcr-abl - genetics (240) 240
efficacy (237) 237
benzamides - therapeutic use (234) 234
cytogenetic responses (233) 233
gastrointestinal stromal tumors - pathology (228) 228
survival (226) 226
interferon-alpha (220) 220
kinases (220) 220
resistance (220) 220
protein kinase inhibitors - pharmacology (218) 218
imatinib mesylate - therapeutic use (217) 217
clinical trials as topic (214) 214
gastrointestinal stromal tumor (214) 214
clinical trials (212) 212
surgery (212) 212
abridged index medicus (210) 210
dose-response relationship, drug (208) 208
time factors (208) 208
neoplasms (207) 207
article (201) 201
kit (201) 201
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3996) 3996
Japanese (73) 73
French (40) 40
Chinese (34) 34
German (28) 28
Spanish (19) 19
Russian (6) 6
Hungarian (4) 4
Polish (3) 3
Czech (2) 2
Dutch (2) 2
Croatian (1) 1
Danish (1) 1
Hebrew (1) 1
Norwegian (1) 1
Slovenian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Association of Physicians of India, ISSN 0004-5772, 12/2018, Volume 66, Issue 12, pp. 79 - 80
Imatinib, a specific tyrosine kinase inhibitor is a new anticancer agent, which has shown excellent efficacy in managing chronic myeloid leukemia. It is well... 
Antineoplastic Agents - adverse effects | Exanthema | Humans | Imatinib Mesylate - adverse effects | Middle Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Dermatitis, Exfoliative - chemically induced | Female
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2017, Volume 35, Issue 3, pp. 298 - 305
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2017, Volume 376, Issue 10, pp. 917 - 927
Journal Article
Annals of Oncology, ISSN 0923-7534, 09/2016, Volume 27, Issue 9, pp. 1794 - 1799
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 5, pp. 612 - 621
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 5, pp. 632 - 641
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2017, Volume 376, Issue 20, pp. 1911 - 1920
Journal Article
Journal Article
Haematologica, ISSN 0390-6078, 05/2016, Volume 101, Issue 6, pp. 717 - 723
Journal Article
International Journal of Molecular Sciences, ISSN 1661-6596, 03/2017, Volume 18, Issue 3, pp. 603 - 603
Journal Article